Press Archive - Arriello

Streamlining Pharmacovigilance.

Streamlining Pharmacovigilance: Why the Inertia? via Pharmaceutical Executive and Arriello's Director of Drug Safety Peter Kohut analyse the findings of a survey on how life sciences companies are capitalizing on opportunities to transform workload and data quality management using the latest smart technology.

Post-Brexit medicines supply continuity.

Earlier this year the European Medicines Agency updated its guidelines, clarifying how to maintain supply of UK-registered products in Europe following December 31. Here, Cecilia Avram, Senior Regulatory Affairs Manager at Arriello, assesses what needs to change.

Pharmacovigilance under scrutiny.

Streamlining Pharmacovigilance.

Why aren’t more companies automating PV data capture?

Raising the bar in pharmacovigilance and regulatory outsourcing.

Post-Brexit medicines supply continuity.